- Home
- LPG vs IMCR Comparison
LPG vs IMCR Comparison
Compare LPG & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LPG | IMCR |
|---|---|---|
| Founded | 2013 | 2008 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.8B |
| IPO Year | 2014 | 2016 |
Fundamental Metrics
Financial Performance| Metric | LPG | IMCR |
|---|---|---|
| Price | $54.59 | $35.98 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 10 |
| Target Price | $39.33 | ★ $66.33 |
| AVG Volume (30 Days) | ★ 480.7K | 360.4K |
| Earning Date | 05-21-2026 | 05-07-2026 |
| Dividend Yield | ★ 8.26% | N/A |
| EPS Growth | ★ 112.15 | 30.39 |
| EPS | ★ 3.24 | 0.23 |
| Revenue | ★ $481,511,242.00 | $249,428,000.00 |
| Revenue This Year | $35.73 | $14.57 |
| Revenue Next Year | N/A | $8.21 |
| P/E Ratio | ★ $16.47 | $163.13 |
| Revenue Growth | 36.27 | ★ 43.05 |
| 52 Week Low | $23.76 | $27.56 |
| 52 Week High | $53.87 | $40.71 |
Technical Indicators
Market Signals| Indicator | LPG | IMCR |
|---|---|---|
| Relative Strength Index (RSI) | 69.17 | 65.09 |
| Support Level | $47.50 | $35.46 |
| Resistance Level | N/A | $40.71 |
| Average True Range (ATR) | 1.63 | 1.20 |
| MACD | 0.19 | 0.02 |
| Stochastic Oscillator | 92.24 | 89.44 |
Price Performance
Historical ComparisonAbout LPG Dorian LPG Ltd.
Dorian LPG Ltd is an international liquefied petroleum gas shipping company focused on owning and operating gas carriers, or VLGCs. The company currently owns and operates around 22 modern VLGCs, including nineteen new fuel-efficient 84,000 cbm ECO-design VLGCs. Dorian LPG has offices in Connecticut, USA, London, United Kingdom, and Athens, Greece. IT operates in one reportable segment, the international transportation of LPG.
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.